Oculis Trial Shows Potential for Optical Neuroprotective Therapy
By Karen Roman Oculis Holding AG (Nasdaq: OCS) said Phase 2 of its neuroprotective candidate OCS-05 met key endpoints of ...
PsyPost on MSN3d
Mediterranean diet’s neuroprotective effects linked to glycemic control
Recent research has uncovered a link between diet, blood sugar control, and brain health in aging adults. The study, ...
devdiscourse5d
Breakthrough in Parkinson’s Research: Nano-Melatonin Shows Enhanced Neuroprotective Properties
Recent studies have identified the significance of mitophagy, a quality control process that removes dysfunctional ...
Drexel University5y
Preclinical Optimization of a Novel Neuroprotective Agent to Treat Parkinson’s Disease
Huntington’s Disease (HD) is a fatally inherited neurodegenerative, orphan disorder affecting 1 in 10,000 individuals with a higher prevalence in Caucasian race. HD is caused by an expanded glutamine ...
Pharmabiz12h
Oculis Holding’s OCS-05 phase 2 ACUITY trial in acute optic neuritis meets primary safety endpoint and key secondary efficacy endpoints
Oculis Holding’s OCS-05 phase 2 ACUITY trial in acute optic neuritis meets primary safety endpoint and key secondary efficacy endpoints: Zug, Switzerland Tuesday, January 7, 202 ...
Nature5y
Indip—a novel neuroprotective agent?
Crucially, neuronal damage was also significantly reduced in rats treated with Indip 120 min after transient middle cerebral artery occlusion, which suggests that this agent has neuroprotective ...
EurekAlert!5d
Artificial intelligence (AI)-based research to revolutionize the future of glaucoma treatment (IMAGE)
The loss of retinal ganglion cells (RGCs) is a prevalent characteristic of glaucoma and often the reason behind disease progression. Now, a team of researchers has utilized AI to identify a RIPK3 ...
Nature4y
ST266—a next-generation anti-inflammatory and neuroprotective platform biologic
The biological factors secreted by these cells have unique anti-inflammatory and neuroprotective effects. Presently, the company is looking for partners to drive clinical drug development of its ...